Avisa Indira

Avisa Indira

Auto-generated profile, based on publicly available information

Avisa Indira

V.V. Institute of Pharmaceutical Sciences

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2024
Verified
Book Chapter
Closed access
PDF file
TBTalamanchi Balakrishna
Talamanchi Balakrishna
LALakshmana Rao Atmakuri
Lakshmana Rao Atmakuri
CPChandika Naga Veera Venkata Pravallika
Chandika Naga Veera Venkata Pravallika
CPCheruku Jigeesha Naga Durga Sai Paidi Pranitha
Cheruku Jigeesha Naga Durga Sai Paidi Pranitha
KSKollipara Baby Lakshmi Sravani
Kollipara Baby Lakshmi Sravani
AIAvisa Indira
Avisa Indira

10 July 2025
Verified
Book Chapter
Closed access
PDF file
TBTalamanchi Balakrishna
Talamanchi Balakrishna
VJVenkateswara Rao Javvaji
Venkateswara Rao Javvaji
RPRaveesha Peeriga
Raveesha Peeriga
SLSonti Lavanya
Sonti Lavanya
AIAvisa Indira
Avisa Indira
MSMonapati Suchitra
Monapati Suchitra
One of the hottest areas that opens up is at the junction of CRISPR technology and microbiome-based therapeutics in the rapidly growing horizon of medical research. This ranges from some genetic diseases to chronic diseases influenced by microbial communities and, therefore, holds much promise therapeutically with mechanisms of precision gene editing mediated by CRISPR-Cas9 and manipulation of the microbiome. This new technology has broken the barriers of precision genome alteration with unprecedented accuracy and efficiency for mankind, and this is something that the CRISPR-Cas9 technology goes beyond. The potential of CRISPR in terms of altering specific DNA sequences looks promising regarding the possibility of making cellular processes more effective, correcting genetic defects responsible for inherited diseases, and advancing discoveries on new medicines. Billions of bacteria live in and on part of the human body. As such, the microbiome is the central aspect of disease states and general health. Technological advances in the omics field-transcriptomics, proteomics, metabolomics, and genomes make it currently possible to offer highly detailed molecular medicine. <!----> <!----> <!----> <!---->

10 July 2025
Verified
Book Chapter
Closed access
PDF file
TBTalamanchi Balakrishna
Talamanchi Balakrishna
CPCheruku Jigeesha Naga Durga Sai Pa Pranitha
Cheruku Jigeesha Naga Durga Sai Pa Pranitha
RPRaveesha Peeriga
Raveesha Peeriga
VJVenkateswara Rao Javvaji
Venkateswara Rao Javvaji
AIAvisa Indira
Avisa Indira
YAYadlapalli Vamsi Abhiram
Yadlapalli Vamsi Abhiram
It is noteworthy that regulatory science affiliates law and politics with science, and is indispensable to preserve and ensure the understanding of the population health, as well as the guaranteed effectiveness and safety of a procedure or a product. The policy areas include developing technology, food and agriculture, medicine and medical devices and the environment. Opportunities and problems are: rapid technological growth, effective market globalization, and advanced scientific development. This chapter addresses the present and future contingents of Regulatory Aspects 20 in the Pharmaceutical World. A case of challenges involved and perspectives drawn paint the picture of the development of the pharmaceutical control in history. The chapter explores new methodological approaches and a technology affecting the regulation processes, identifies further regulation trends, and provides recommendations for the future of pharmaceutical regulations. <!----> <!----> <!----> <!---->

26 June 2024
Verified
Book Chapter
Closed access
PDF file
BTBalakrishna Talamanchi
Balakrishna Talamanchi
MBMOHAN GANDHI BONTHU
MOHAN GANDHI BONTHU
PAPavani Gayatri Alluri
Pavani Gayatri Alluri
AIAvisa Indira
Avisa Indira